Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 60.11
-3.97 (-6.20%)
Last updated: Oct 22, 2025, 9:30 AM CST
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 27.78 billion as of October 24, 2025. Its market cap has increased by 99.04% in one year.
Market Cap
27.78B
Enterprise Value
26.71B
Revenue
511.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.11
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 27.78B, an increase of 68.98%. That is a compound annual growth rate of 14.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 27.78B | 61.17% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 435.31B |
| WuXi AppTec | 306.37B |
| Shenzhen Mindray Bio-Medical Electronics | 268.24B |
| Sichuan Biokin Pharmaceutical | 145.00B |
| Shanghai United Imaging Healthcare | 114.80B |
| Aier Eye Hospital Group | 114.06B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.03B |
| Yunnan Baiyao Group Co.,Ltd | 100.94B |